Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Diabetes

Free Subscription 22.06.2026 1 Am J Epidemiol 1 Am J Kidney Dis 1 Am J Med 1 Ann Intern Med 1 Atherosclerosis 1 BMC Pediatr 2 BMJ 6 Diabet Med 7 Diabetes Care 23 Diabetes Obes Metab 1 Invest Ophthalmol Vis Sci 7 J Clin Endocrinol Metab 1 J Clin Invest 1 J Diabetes Complications 1 J Immunol 5 J Nutr 7 JAMA 2 Kidney Int 1 Lancet 1 Metabolism 1 Nutr Metab (Lond) 2 Obstet Gynecol 6 PLoS One 2 Retina

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Epidemiol

1. MENDOZA K, Marrero A, Tamez M, Espinosa A, et al
   Ultra-processed foods and incident type 2 diabetes: Analysis of the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
   Am J Epidemiol. 2026 Jun 17:kwag139. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Am J Kidney Dis

2. NEUMILLER JJ, Deng Y, Swarna KS, Polley EC, et al
   Comparison of Specific Glucagon-Like Peptide-1 Receptor Agonists on Kidney Outcomes Among Patients With Type 2 Diabetes.
   Am J Kidney Dis. 2026 Jun 16:S0272-6386(26)00964.
   PubMed         Abstract available
   
   

   
   Am J Med

3. JAISWAL V, Mashkoor Y, Waqas M, Khan MS, et al
   All-cause and cause-specific mortality assessment in patients receiving sodium glucose co-transporter-2 inhibitors.
   Am J Med. 2026;139:1032-1042.
   PubMed         Abstract available
   
   

   
   Ann Intern Med

4. LAU D
   In T2D inadequately controlled with metformin, orforglipron reduced HbA(1c) more than oral semaglutide at 52 wk.
   Ann Intern Med. 2026;179:JC62.
   PubMed         Abstract available
   
   

   
   Atherosclerosis

5. CENKO E, Yoon J, Bergami M, Vasiljevic Z, et al
   Standard modifiable cardiovascular risk factors and acute coronary syndrome free survival.
   Atherosclerosis. 2026;417:120616.
   PubMed         Abstract available
   
   

   
   BMC Pediatr

6. DOLAK KD, Davila S, White PC
   Procalcitonin levels as a predictor of antibiotic treatment in pediatric diabetic ketoacidosis.
   BMC Pediatr. 2026 Jun 17. doi: 10.1186/s12887-026-07114.
   PubMed         Abstract available
   
   

   
   BMJ

7. TANNE JH
   Trump: ADA president elect resigns after US doctors are ejected from diabetes meeting.
   BMJ. 2026;393:e327847.
   PubMed        
   
   
8. NATHAN DM
   American Diabetes Association controversy: Activism is necessary to protect scientific freedom.
   BMJ. 2026;393:e555118.
   PubMed        
   
   

   
   Diabet Med

9. ZENG Y, Sun L, Li J, Huang Z, et al
   The long non-coding RNA KDM4A-AS1 protects beta-cell function via the miR-423-5p/growth differentiation factor 11 axis.
   Diabet Med. 2026;43:e70309.
   PubMed         Abstract available
   
   
10. JIANG Y, Pang X, Zhang Z, Xie S, et al
    Acute pancreatitis following sleeve gastrectomy with transit bipartition: A case report.
    Diabet Med. 2026;43:e70326.
    PubMed         Abstract available
    
    
11. PATTERSON AI, Ruggles H, Dewalt DA, Vitale RJ, et al
    Clinic visit no-shows and last-minute cancellations are common among teens and emerging adults with type 1 diabetes.
    Diabet Med. 2026 Jun 12:e70390. doi: 10.1111/dme.70390.
    PubMed         Abstract available
    
    
12. BOURNE JE, Cranston K, Dineen T, MacPherson M, et al
    A 4-week community-implemented diabetes prevention program is associated with improved metabolic outcomes at 12 months after participation.
    Diabet Med. 2026 Jun 17:e70387. doi: 10.1111/dme.70387.
    PubMed         Abstract available
    
    
13. FORDE R, Forbes A, Adams D, Esmer AC, et al
    Women living with diabetes: Overlooked and under-recognised, the psychosocial impact.
    Diabet Med. 2026 Jun 18:e70389. doi: 10.1111/dme.70389.
    PubMed         Abstract available
    
    
14. GHAFOOR B, Zaccardi F, Khunti K, Shabnam S, et al
    Comparative predictive accuracy of machine learning versus traditional statistical methods for diabetes-related complications: A systematic review and analysis.
    Diabet Med. 2026 Jun 18:e70398. doi: 10.1111/dme.70398.
    PubMed         Abstract available
    
    

    
    Diabetes Care

15. COOK DA, Perna-Barrull D, Murillo M, Vives-Pi M, et al
    Exercise-Induced Immune Modulation in Type 1 Diabetes: From Mechanisms to Clinical Perspectives.
    Diabetes Care. 2026 Jun 12:dci260044. doi: 10.2337/dci26-0044.
    PubMed         Abstract available
    
    
16. WANG Y, Tang S, Zhou X, Zhang P, et al
    National Trends in Out-of-Pocket Cost for Glucose-Lowering Drugs Among U.S. Adults With Diabetes, 2000-2022.
    Diabetes Care. 2026 Jun 16:dc252040. doi: 10.2337/dc25-2040.
    PubMed         Abstract available
    
    
17. RODRIGUEZ DE VERA GOMEZ P, Mayoral E, Rodriguez Jimenez B, Gomez-Peralta F, et al
    Implementation of Intermittently Scanned Continuous Glucose Monitoring and Changes in Hospitalizations and Health Care Costs in Insulin-Treated Type 2 Diabetes.
    Diabetes Care. 2026 Jun 16:dc260547. doi: 10.2337/dc26-0547.
    PubMed         Abstract available
    
    
18. GUDEMANN LM, Angwin C, Holman RR, Sattar N, et al
    To Cluster or Not to Cluster? A Comparison of Approaches to Targeting Type 2 Diabetes Glucose-Lowering Therapy in the TriMaster Crossover Trial.
    Diabetes Care. 2026 Jun 18:dc260118. doi: 10.2337/dc26-0118.
    PubMed         Abstract available
    
    
19. RUELAS V, Bernstein M, Flores Garcia J, Topalis K, et al
    Impact of Prior Authorization Suspension on Access to Diabetes Technology in an Underserved Population: A Retrospective Analysis.
    Diabetes Care. 2026 Jun 18:dc260284. doi: 10.2337/dc26-0284.
    PubMed         Abstract available
    
    
20. REAVEN PD, Macwan SA, McConeghy K, Norman GJ, et al
    Continuous Glucose Monitoring (CGM) Initiation Is Associated With Reduced Mortality in Older-Onset Type 1 Diabetes Patients: A Target Trial Emulation Study Within the Veterans Health Administration.
    Diabetes Care. 2026 Jun 19:dc260425. doi: 10.2337/dc26-0425.
    PubMed         Abstract available
    
    
21. FWU CW, Casagrande SS, Lawrence JM
    Trends in Pregestational and Gestational Diabetes Mellitus and Associations With Severe Maternal Morbidity in U.S. Delivery Hospitalizations, 2016-2022.
    Diabetes Care. 2026 Jun 19:dc260586. doi: 10.2337/dc26-0586.
    PubMed         Abstract available
    
    

    
    Diabetes Obes Metab

22. AL-SOFIANI ME, Alaasmi AA, Altamaimi A, Kalyani RR, et al
    Smartphone-Based Automated Basal Insulin Titration During Ramadan Fasting: Data From Adults With Type 2 Diabetes in Saudi Arabia.
    Diabetes Obes Metab. 2026 Jun 15. doi: 10.1111/dom.70908.
    PubMed         Abstract available
    
    
23. LU FM, Lim YQ, Yu YT, Kao SK, et al
    Elevated Cardiovascular Risk and Mortality in Type 2 Diabetes Mellitus Patients With Cannabis, Opioid, and Cocaine Use Disorders.
    Diabetes Obes Metab. 2026 Jun 15. doi: 10.1111/dom.70981.
    PubMed         Abstract available
    
    
24. LAITINEN A, Karajamaki A, Karajamaki AJ, Kurki S, et al
    Subgroups of Adult-Onset Diabetes: A Prospective Follow-Up Study of Progression of Insulin Resistance and Deficiency and Association With Liver Steatosis and Fibrosis.
    Diabetes Obes Metab. 2026 Jun 15. doi: 10.1111/dom.70983.
    PubMed         Abstract available
    
    
25. PIONA C, Chobot A, Weiskorn J, Shankar A, et al
    Association of Time in Range and Time in Tight Range With Cardiovascular Risk Factor Exposure in Youth With Type 1 Diabetes: A Cross-Sectional Analysis on LDL Cholesterol and Blood Pressure Data From the SWEET International Database.
    Diabetes Obes Metab. 2026 Jun 15. doi: 10.1111/dom.70979.
    PubMed         Abstract available
    
    
26. YAU YK, Li M, Quan J, Grepin KA, et al
    Association of Reduction in Continuity of Care During COVID-19 Pandemic With Cardiovascular Diseases, Kidney Failure and All-Cause Mortality for People With Diabetes: A Cohort Study in Hong Kong.
    Diabetes Obes Metab. 2026 Jun 15. doi: 10.1111/dom.70984.
    PubMed         Abstract available
    
    
27. CICHOSZ SL, Faerch K, Jensen MH
    Characterising Continuous Glucose Monitoring Metrics Across Normoglycaemia, Prediabetes and Type 2 Diabetes.
    Diabetes Obes Metab. 2026 Jun 15. doi: 10.1111/dom.71008.
    PubMed        
    
    
28. JANG MK, Jung CH, Lee HS, Lee A, et al
    Enavogliflozin Improves Non-invasive Hepatic Steatosis Indices in Patients With Type 2 Diabetes: A Pooled Analysis of Three Randomised Trials.
    Diabetes Obes Metab. 2026 Jun 15. doi: 10.1111/dom.71007.
    PubMed        
    
    
29. D'SOUZA NC, Hoffman EG, Atherley SC, Champsi S, et al
    One Week Exposure to a Somatostatin Receptor 2 Antagonist (SSTR2a) Enhances Glucagon Counterregulation to Insulin-Induced Hypoglycaemia and Does Not Worsen Glycemia in a Male Rat Model of Insulin-Requiring Type 2 Diabetes.
    Diabetes Obes Metab. 2026 Jun 18. doi: 10.1111/dom.71012.
    PubMed         Abstract available
    
    
30. LIU C, Yu M, Lee IXY, O'Donnell GP, et al
    Diabetic Corneal Neuropathy as a Window Into Diabetic Foot Risk: A Large-Scale Association Study.
    Diabetes Obes Metab. 2026 Jun 18. doi: 10.1111/dom.71021.
    PubMed         Abstract available
    
    
31. PERKINS RK, Mazo CE, Shadiow J, Varshney P, et al
    Aerobic Exercise Training Increases Circulating sRAGE in Adults With Type 2 Diabetes: Associations With Sheddase Regulation.
    Diabetes Obes Metab. 2026 Jun 17. doi: 10.1111/dom.70995.
    PubMed         Abstract available
    
    
32. LUX TS, Lee D, Phillips JM, Facelli JC, et al
    Prescribing Trajectories in Type 2 Diabetes in the United States, 2019-2024.
    Diabetes Obes Metab. 2026 Jun 17. doi: 10.1111/dom.71013.
    PubMed         Abstract available
    
    
33. KANAT M, Abdul-Ghani M, DeFronzo RA
    How the First 9 Months Shape the Rest of Your Life: The Impact of Gestational Diabetes on the Metabolic Future.
    Diabetes Obes Metab. 2026 Jun 17. doi: 10.1111/dom.70987.
    PubMed         Abstract available
    
    
34. RICHARDSON RR
    Insulin Activity Varies Widely Across Equivalent Episodes of Hypoglycaemia in Type 1 Diabetes.
    Diabetes Obes Metab. 2026 Jun 16. doi: 10.1111/dom.71024.
    PubMed        
    
    
35. DE FANO M, Tortoriello R, Rucco S, Corio S, et al
    Tirzepatide for Excess Weight in Adults With Type 1 Diabetes Using MiniMed 780G.
    Diabetes Obes Metab. 2026 Jun 16. doi: 10.1111/dom.71002.
    PubMed        
    
    
36. ZOU X, Chandran M, Xiong X, Lee CH, et al
    Type 2 Diabetes Is Associated With Increased Complications and Mortality After Hip Fracture in Older Adults Aged 60 Years or Older.
    Diabetes Obes Metab. 2026 Jun 16. doi: 10.1111/dom.71000.
    PubMed         Abstract available
    
    
37. VADSHOLT D, Kvist AV, Sandiramoorthy C, Lewis JR, et al
    Dose-Response Association Between Systemic and Dermatologic Glucocorticoid Use and Type 2 Diabetes Mellitus: A Nationwide Case-Control Study.
    Diabetes Obes Metab. 2026 Jun 16. doi: 10.1111/dom.71001.
    PubMed         Abstract available
    
    
38. BUNZEL K, Sanfilippo S, Schierbauer J, Schuster L, et al
    Long-Term Associations Between Energy Expenditure and CGM-Derived Metrics in Adults With Type 1 Diabetes: A Retrospective Analysis of the Syntactiq Cockpit Database.
    Diabetes Obes Metab. 2026 Jun 16. doi: 10.1111/dom.71003.
    PubMed        
    
    
39. MARTINS KPMP, Barreto SM, Camelo LV, Menezes ST, et al
    Endothelial Function Is Associated With Incident Diabetes Mellitus: The ELSA-Brasil Cohort Study.
    Diabetes Obes Metab. 2026 Jun 16. doi: 10.1111/dom.71014.
    PubMed         Abstract available
    
    
40. HINTON W, Joy M, Forbes AK, Whyte MB, et al
    Combining Sodium-Glucose Co-Transporter-2 Inhibitor Plus Glucagon-Like Peptide-1 Receptor Agonist for Glucose-Lowering in Type 2 Diabetes: Effects of Drug Initiation Sequence on Kidney Function in Real-World Clinical Practice (CombiKid Study).
    Diabetes Obes Metab. 2026 Jun 16. doi: 10.1111/dom.70946.
    PubMed         Abstract available
    
    
41. KARUNAKARAN V, Pedersen IB, Hjelholt A, Kjolby M, et al
    Influenza Vaccination Among Individuals With Type 1 Diabetes in Denmark: Coverage, Persistence, and Determinants, 2015-2022.
    Diabetes Obes Metab. 2026 Jun 14. doi: 10.1111/dom.70965.
    PubMed         Abstract available
    
    
42. DURAND CP, Eatherly M, Yao A, Dollear TJ, et al
    Healthcare Cost Trends in New Users of SGLT-2i, DPP-4i and GLP-1 RA for Type 2 Diabetes: An Observational Longitudinal Study.
    Diabetes Obes Metab. 2026 Jun 14. doi: 10.1111/dom.70923.
    PubMed         Abstract available
    
    
43. ENGSTROM A, Svanstrom H, Hviid A, Eliasson B, et al
    Use of Glucagon-Like Peptide-1 Receptor Agonists and Risk of Parkinson's Disease: Scandinavian Cohort Study.
    Diabetes Obes Metab. 2026;28:5767-5778.
    PubMed         Abstract available
    
    
44. HASEBE M, Kamido H, Su CY, Keidai Y, et al
    Estimated Glomerular Filtration Rate Change and Heart Failure Events With GLP-1 Receptor Agonists: A Meta-Analysis and Meta-Regression of Randomised Controlled Trials.
    Diabetes Obes Metab. 2026;28:5649-5657.
    PubMed         Abstract available
    
    

    
    Invest Ophthalmol Vis Sci

45. YU J, Gao YL, Zhang Y, Xu JM, et al
    Associations of Multiomics Biological Aging With Diabetic Retinopathy and Life Expectancy.
    Invest Ophthalmol Vis Sci. 2026;67:36.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

46. LUNATI ME, Cimino V, Bernasconi D, Romano C, et al
    The use of semaglutide as an add-on therapy in patients with latent autoimmune diabetes in adults.
    J Clin Endocrinol Metab. 2026;111:1842-1849.
    PubMed         Abstract available
    
    
47. COMFORT L, Benjamin A, Brenner E, Krantz D, et al
    The need for pharmacotherapy among patients with one or more elevations on glucose tolerance test.
    J Clin Endocrinol Metab. 2026;111:1940-1948.
    PubMed         Abstract available
    
    
48. LIU Y, Walzer D, Schmitz S, Shukla AP, et al
    Skeletal Effect of Semaglutide and Tirzepatide in Patients with Increased Risk of Fractures.
    J Clin Endocrinol Metab. 2026 Feb 7:dgag052. doi: 10.1210.
    PubMed         Abstract available
    
    
49. SCIFRES CM, Sinha A, Orris S, Costacou T, et al
    Metabolic outcomes at 12 months postpartum among individuals with glucose intolerance in pregnancy.
    J Clin Endocrinol Metab. 2026 Feb 2:dgag035. doi: 10.1210.
    PubMed         Abstract available
    
    
50. IMPRODA N, Katugampola H, Cerbone M, Shah P, et al
    Clinical spectrum of extreme insulin resistance syndromes treated with rhIGF-1: A single-center experience.
    J Clin Endocrinol Metab. 2026;111:2049-2063.
    PubMed         Abstract available
    
    
51. PARIKH M, Pu J, Shen J, Kramer CK, et al
    Exenatide induces an enhanced endogenous glucagon-like peptide-1 secretory response in patients receiving basal insulin.
    J Clin Endocrinol Metab. 2026;111:e1884-e1891.
    PubMed         Abstract available
    
    
52. KUSINSKI LC, Liu Z, Dib S, Rogers R, et al
    Association Between Polycystic Ovary Syndrome and Pregnancy Outcomes in GDM: A Secondary Analysis of the DiGest Trial.
    J Clin Endocrinol Metab. 2026 Jan 28:dgag026. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Clin Invest

53. PACIFICO P, George D, Jayaraj ND, Ren D, et al
    Skin-resident Langerhans cells drive neuropathic pain via chemokine-dependent neuron-immune communication.
    J Clin Invest. 2026;136:e192328.
    PubMed         Abstract available
    
    

    
    J Diabetes Complications

54. NOMIKOS M, Rizzo M, AlMakadma A
    From obesity guideline to diabetes practice: WHO GLP-1 recommendations between promise, uncertainty and global inequity.
    J Diabetes Complications. 2026 Jun 12:109361.
    PubMed        
    
    

    
    J Immunol

55. PANG J, Lukas B, Roberts R, Maienschein-Cline M, et al
    A novel monocyte-derived antigen presenting cell-T regulatory cell axis contributes to skin wound healing and is impaired in diabetic mice.
    J Immunol. 2026;215:vkag128.
    PubMed         Abstract available
    
    

    
    J Nutr

56. URIBARRI J, Calvo MS
    Could an Ultra-Processed Food for Special Dietary Use Advance Personalized Medicine in Diabetic Nephropathy?
    J Nutr. 2026 Jun 18:101679. doi: 10.1016/j.tjnut.2026.101679.
    PubMed        
    
    
57. MINARI TP, Vilela-Martin JF, Yugar-Toledo JC, Pisani LP, et al
    Effects of a 12-Month Nutritional Intervention on Ambulatory Blood Pressure and Nocturnal Dipping in Patients with Type 2 Diabetes, Hypertension, and Overweight or Obesity.
    J Nutr. 2026 Jun 17:101675. doi: 10.1016/j.tjnut.2026.101675.
    PubMed         Abstract available
    
    
58. JANCSURA MK, Grobman WA, Wu J, Griffis HM, et al
    Association between a periconception healthy plant-based diet and adverse pregnancy outcomes.
    J Nutr. 2026 May 2:101577. doi: 10.1016/j.tjnut.2026.101577.
    PubMed         Abstract available
    
    
59. REHMAN Z, Altonji OM, Steger FL, Jamshed H, et al
    Do the Effects of Early Time-Restricted Eating Vary by Cardiometabolic Phenotype, Age, Sex, or Race? A Secondary Analysis of a Randomized Controlled Trial.
    J Nutr. 2026;156:101526.
    PubMed         Abstract available
    
    
60. MENCUCCI MV, Lacunza E, Abba MC, Ahrtz L, et al
    Characterization of Blood DNA Methylation Changes in a Murine Model of Prediabetes Induced by Fructose and Its Reversal.
    J Nutr. 2026;156:101522.
    PubMed         Abstract available
    
    

    
    JAMA

61. FLOREZ H, Foster C, Vizcaino G
    Addressing Multimorbidity Challenges in Diabetes-Lifestyle and Beyond.
    JAMA. 2026 Jun 15. doi: 10.1001/jama.2026.10080.
    PubMed        
    
    
62. ZHANG S, Ran A, Zhou J, Ling A, et al
    An AI-Based OCT System to Detect Diabetic Macular Edema: A Prospective Validation and Noninferiority Randomized Clinical Trial.
    JAMA. 2026 Jun 15:e267025. doi: 10.1001/jama.2026.7025.
    PubMed         Abstract available
    
    
63. POTTER SR, El Chediak A, Parsons RF
    Review of Type 1 Diabetes.
    JAMA. 2026 Jun 17. doi: 10.1001/jama.2026.6463.
    PubMed        
    
    
64. JONES SI, Boettcher LB, Kuller JA
    Review of Type 1 Diabetes.
    JAMA. 2026 Jun 17. doi: 10.1001/jama.2026.6460.
    PubMed        
    
    
65. GARCIA BERNAL GC, Nunez Soria AA, Bernal Gonzalez DA
    Review of Type 1 Diabetes.
    JAMA. 2026 Jun 17. doi: 10.1001/jama.2026.6457.
    PubMed        
    
    
66. SCHATZ DA, Jacobsen LM
    Review of Type 1 Diabetes-Reply.
    JAMA. 2026 Jun 17. doi: 10.1001/jama.2026.6466.
    PubMed        
    
    
67. ABBASI J
    A New GLP-1 Pill for Diabetes, Semaglutide With Amylin, Data From China, and More From ADA 2026.
    JAMA. 2026 Jun 18. doi: 10.1001/jama.2026.7591.
    PubMed        
    
    

    
    Kidney Int

68. CERSOSIMO E, DeFronzo RA
    Role of the Kidney in Glucose Homeostasis: The Basis for Pharmacotherapy and Prevention of Cardio-Renal Complications in Diabetes.
    Kidney Int. 2026 Jun 16:S0085-2538(26)00474-6. doi: 10.1016/j.kint.2026.
    PubMed         Abstract available
    
    
69. OSTERGAARD JA, Cooper ME
    Resolving the VEGF paradox in DKD: VEGFR1 blockade shows promising renoprotection.
    Kidney Int. 2026;110:33-34.
    PubMed         Abstract available
    
    

    
    Lancet

70. DAVIES MJ, Aroda VR, Rosenstock J, Capehorn M, et al
    Elecoglipron, an oral small molecule GLP-1 receptor agonist in adults with obesity or overweight (VISTA): a multicentre, phase 2, randomised, placebo-controlled clinical trial.
    Lancet. 2026 Jun 8:S0140-6736(26)00748-8. doi: 10.1016/S0140-6736(26)00748.
    PubMed         Abstract available
    
    

    
    Metabolism

71. FERRARI D, Bonaventura I, Tenuta M, Pofi R, et al
    Rethinking hypercortisolism screening in obesity and diabetes: A systematic review and meta-analysis.
    Metabolism. 2026 Jun 14:156675. doi: 10.1016/j.metabol.2026.156675.
    PubMed         Abstract available
    
    

    
    Nutr Metab (Lond)

72. WANG L, Song L, Fan J
    Trends and disparities in glycemic control and severe hyperglycemia in U.S. adults with diabetes mellitus before and during COVID-19 pandemic.
    Nutr Metab (Lond). 2026 Jun 12. doi: 10.1186/s12986-026-01156.
    PubMed         Abstract available
    
    

    
    Obstet Gynecol

73. ANTHONY K, Battarbee A
    Reimagining Postpartum Diabetes Screening: From Immediate Oral Glucose Tolerance Testing to Innovative Strategies.
    Obstet Gynecol. 2026;148:1-3.
    PubMed        
    
    
74. BASTIAN IN, Gandhi M, Turrentine MA
    Evaluation of Postpartum Glucose Tolerance Test Results Based on Criteria and Timing.
    Obstet Gynecol. 2026;148:4-10.
    PubMed         Abstract available
    
    

    
    PLoS One

75. NICKLETT EJ, Stensland ML, Qin W, Walker T, et al
    "You never know what's in front of you": A mixed methods study of barriers and facilitators to physical activity among blind and low-vision adults with type 2 diabetes.
    PLoS One. 2026;21:e0332565.
    PubMed         Abstract available
    
    
76. LIANAWATI, Laohasiriwong W, Htike KM, Thinkhamrop K, et al
    Survival analysis of time to amputation following diabetic foot ulcer diagnosis among Indonesians.
    PLoS One. 2026;21:e0343399.
    PubMed         Abstract available
    
    
77. XU H, Wu C, Zhang L, Ju Y, et al
    The effectiveness of a foot-care education program based on multi-theory model in diabetic patients with risk of foot ulceration: A randomized controlled trial protocol.
    PLoS One. 2026;21:e0350892.
    PubMed         Abstract available
    
    
78. LI Y, Haron A, Lin C, Tang Y, et al
    A scoping review of computational models of the diabetic foot.
    PLoS One. 2026;21:e0351638.
    PubMed         Abstract available
    
    
79. LUK HY, Appell CR, Zhang F, Blinch J, et al
    Effects of local heat on metabolic health, frailty risk, and exercise adaptations in pre-diabetic older adults: Protocol for the Heat and Exercise in Aging as Therapy (HEAT) clinical trial.
    PLoS One. 2026;21:e0351577.
    PubMed         Abstract available
    
    
80. AHMAD A, Khan IU, Jamil Y, Ajmal A, et al
    Production of anti-inflammatory and antidiabetic oligosaccharides from okra mucilage through one-step microbial fermentation.
    PLoS One. 2026;21:e0351134.
    PubMed         Abstract available
    
    

    
    Retina

81. LISHINSKY-FISCHER N, Levy J
    PROSTACYCLIN ANALOGS AND DIABETIC RETINOPATHY OUTCOMES IN PATIENTS WITH PULMONARY HYPERTENSION : A Cohort Analysis.
    Retina. 2026;46:1251-1257.
    PubMed         Abstract available
    
    
82. SATHER RN 3RD, Chiang T, Moon JY, Dev S, et al
    REAL-WORLD DURABILITY OF AFLIBERCEPT 8 MG AND FARICIMAB IN INITIATORS VERSUS SWITCHERS: A Multicenter Retrospective Analysis.
    Retina. 2026;46:1231-1240.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum